About Axiogenesis
Axiogenesis is a Healthcare company based in Koln (Germany) founded in 2000. Generic medicines are sold via an online pharmacy platform. Its Indian entity Ironsource India Private Limited reported revenue of ₹21.75 Cr. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its competitors include MAYD, medpex and Medizinfuchs; 1 of its 3 listed competitors has raised funding.
Company details
Axiogenesis was established in 2000 in Cologne, Germany, as an online pharmacy. Generic medicines are distributed through the platform, which operates in the healthcare sector. Specific drugs can be searched by users according to their requirements. The service focuses on pharmaceutical accessibility, with operations centered in Europe. The domain axiogenesis.com supports these activities.
- Headquarters Koln, Germany
- SectorsHealthcare
- Website axiogenesis.com
- Social LinkedIn X
- Legal Name Ironsource India Private Limited
- Date of Incorporation 26 Apr, 2016
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹21.75 Cr
FY 2025 · +206% YoY
- Indian entity net profit₹3.79 Cr
FY 2025 · 17% margin
- Indian entity EBITDA₹5.88 Cr
FY 2025 · 27% margin
- Latest Funding Round$615.66K (USD), Grant
Nov 2016
- InvestorsEuropean Union
& 1 more
Associated legal entities of Axiogenesis
Axiogenesis operates through Ironsource India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ironsource India Private Limited CIN U74300KA2016FTC092539 | Active | 26 Apr 2016 | Bangalore, Karnataka | ₹21.7 Cr | 21 | 4 | View details |
Funding Insights of Axiogenesis
- Total Rounds 3
- Last Round Grant — $615,661
- First Round $373,293
(Jun 2015)
- Investors Count 2
All 3 funding rounds of Axiogenesis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2016 | $615,661 | Grant | – | – | |
| May 2016 | Series A | – | Sino-German High-Tech Fund | – | |
| Jun 2015 | $373,293 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Axiogenesis
Axiogenesis has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Huizhong Diagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Huizhong Diagnostics is engaged in developing medical diagnostic solutions. | sghtfund.com | Shanghai, China | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Axiogenesis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ironsource India Private Limited (Axiogenesis)
Ironsource India Private Limited is the primary company behind Axiogenesis. The board of Ironsource India Private Limited currently have 4 directors; the longest-serving is Nora Sen Go, appointed in 2024. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nora Sen Go DIN 10531941 | Director | 04 Mar 2024 | 2 yrs 8 mo | Ironsource India Private Limited |
| Bhagavant Bedi DIN 08005696 | Director | 21 Nov 2024 | 1 yr 11 mo | Ironsource India Private Limited |
| Jasmine De Layton DIN 10792925 | Director | 08 Jul 2025 | 1 yr 4 mo | Ironsource India Private Limited |
| Shridhar Subbaraman Iyer DIN 07151577 | Director | 30 Oct 2025 | 1 yr | Ironsource India Private Limited |
Financials of Axiogenesis
Figures of Ironsource India Private Limited, the primary company behind Axiogenesis, for FY 2025. Revenue was ₹21.75 Cr (+206% year on year). Net profit was ₹3.79 Cr (17% margin). EBITDA was ₹5.88 Cr (27% margin). Revenue has grown at a compounded annual rate of +87% over three years and +59% over five years.
- ₹21.75 CrRevenue · FY 2025 · +206% YoY
- ₹3.79 CrNet profit · 17% margin
- ₹5.88 CrEBITDA · 27% margin
- ₹1 LakhPaid-up capital
- 21Employees (provident fund records)
- +87%Revenue CAGR, 3 years
- +59%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ironsource India Private Limited are on its company page.
Detailed financial statements for Axiogenesis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Axiogenesis
3 dated milestones of Axiogenesis across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Axiogenesis is founded.
- Funding First funding round of $373K.
- Funding Latest funding round, Grant, of $616K.
Competitors of Axiogenesis
Axiogenesis has 3 listed competitors in our database, 1 of them funded. They include MAYD, medpex and Medizinfuchs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| getmayd.com | 2018 | Berlin, Germany | $48.88M | Non-prescription medicines are ordered and delivered online. | ||
| medpex.de | 2005 | Ludwigshafen, Germany | Medicines for health conditions are sold online by medpex. | |||
| medizinfuchs.de | 2009 | Berlin, Germany | Operates a marketplace for pharmacy products to facilitate online purchasing. |
Detailed competitors of Axiogenesis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Axiogenesis
The website of Axiogenesis (axiogenesis.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 125.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Axiogenesis
Complete news archive for Axiogenesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axiogenesis
Axiogenesis was founded in 2000 and raised its 1st funding round 15 years after it was founded.
Axiogenesis is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.
The primary company behind Axiogenesis, Ironsource India Private Limited, reported revenue of ₹21.75 Cr for FY 2025, up 206% year on year.
Axiogenesis was established in 2000 in Cologne, Germany, as an online pharmacy. Generic medicines are distributed through the platform, which operates in the healthcare sector. Specific drugs can be searched by users according to their requirements. The service focuses on pharmaceutical accessibility, with operations centered in Europe. The domain axiogenesis.com supports these activities.
Axiogenesis's top competitors include MAYD, medpex and Medizinfuchs.
Axiogenesis has 2 investors. Key investors include European Union, and Huizhong Diagnostics.
Axiogenesis operates through Ironsource India Private Limited.
The legal entities of Axiogenesis currently have 4 directors, including Nora Sen Go, Bhagavant Bedi, Shridhar Subbaraman Iyer and others.